Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
This report aims to provide a comprehensive presentation of the global market for Anthrax Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthrax Vaccines. This report contains market size and forecasts of Anthrax Vaccines in global, including the following market information:
Global Anthrax Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anthrax Vaccines Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Anthrax Vaccines companies in 2022 (%)
The global Anthrax Vaccines market was valued at US$ 674 million in 2022 and is projected to reach US$ 1101.7 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
We surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthrax Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, by Type, 2022 (%)
Live Vaccines
Cell free PA Vaccines
Global Anthrax Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, by Application, 2022 (%)
Human Use
Animal Use
Global Anthrax Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthrax Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anthrax Vaccines revenues share in global market, 2022 (%)
Key companies Anthrax Vaccines sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Anthrax Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biog?nesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Sant? Animale
Intervac
JOVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anthrax Vaccines, market overview.
Chapter 2: Global Anthrax Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Anthrax Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anthrax Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anthrax Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anthrax Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anthrax Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anthrax Vaccines Overall Market Size
2.1 Global Anthrax Vaccines Market Size: 2022 VS 2029
2.2 Global Anthrax Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anthrax Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Anthrax Vaccines Players in Global Market
3.2 Top Global Anthrax Vaccines Companies Ranked by Revenue
3.3 Global Anthrax Vaccines Revenue by Companies
3.4 Global Anthrax Vaccines Sales by Companies
3.5 Global Anthrax Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anthrax Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anthrax Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anthrax Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Anthrax Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anthrax Vaccines Market Size Markets, 2022 & 2029
4.1.2 Live Vaccines
4.1.3 Cell free PA Vaccines
4.2 By Type - Global Anthrax Vaccines Revenue & Forecasts
4.2.1 By Type - Global Anthrax Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Anthrax Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Anthrax Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Anthrax Vaccines Sales & Forecasts
4.3.1 By Type - Global Anthrax Vaccines Sales, 2018-2023
4.3.2 By Type - Global Anthrax Vaccines Sales, 2024-2029
4.3.3 By Type - Global Anthrax Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anthrax Vaccines Market Size, 2022 & 2029
5.1.2 Human Use
5.1.3 Animal Use
5.2 By Application - Global Anthrax Vaccines Revenue & Forecasts
5.2.1 By Application - Global Anthrax Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Anthrax Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Anthrax Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Anthrax Vaccines Sales & Forecasts
5.3.1 By Application - Global Anthrax Vaccines Sales, 2018-2023
5.3.2 By Application - Global Anthrax Vaccines Sales, 2024-2029
5.3.3 By Application - Global Anthrax Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anthrax Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Anthrax Vaccines Revenue & Forecasts
6.2.1 By Region - Global Anthrax Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Anthrax Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Anthrax Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Anthrax Vaccines Sales & Forecasts
6.3.1 By Region - Global Anthrax Vaccines Sales, 2018-2023
6.3.2 By Region - Global Anthrax Vaccines Sales, 2024-2029
6.3.3 By Region - Global Anthrax Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anthrax Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Anthrax Vaccines Sales, 2018-2029
6.4.3 US Anthrax Vaccines Market Size, 2018-2029
6.4.4 Canada Anthrax Vaccines Market Size, 2018-2029
6.4.5 Mexico Anthrax Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anthrax Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Anthrax Vaccines Sales, 2018-2029
6.5.3 Germany Anthrax Vaccines Market Size, 2018-2029
6.5.4 France Anthrax Vaccines Market Size, 2018-2029
6.5.5 U.K. Anthrax Vaccines Market Size, 2018-2029
6.5.6 Italy Anthrax Vaccines Market Size, 2018-2029
6.5.7 Russia Anthrax Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Anthrax Vaccines Market Size, 2018-2029
6.5.9 Benelux Anthrax Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anthrax Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Anthrax Vaccines Sales, 2018-2029
6.6.3 China Anthrax Vaccines Market Size, 2018-2029
6.6.4 Japan Anthrax Vaccines Market Size, 2018-2029
6.6.5 South Korea Anthrax Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Anthrax Vaccines Market Size, 2018-2029
6.6.7 India Anthrax Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anthrax Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Anthrax Vaccines Sales, 2018-2029
6.7.3 Brazil Anthrax Vaccines Market Size, 2018-2029
6.7.4 Argentina Anthrax Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anthrax Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anthrax Vaccines Sales, 2018-2029
6.8.3 Turkey Anthrax Vaccines Market Size, 2018-2029
6.8.4 Israel Anthrax Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Anthrax Vaccines Market Size, 2018-2029
6.8.6 UAE Anthrax Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Emergent BioSolutions
7.1.1 Emergent BioSolutions Company Summary
7.1.2 Emergent BioSolutions Business Overview
7.1.3 Emergent BioSolutions Anthrax Vaccines Major Product Offerings
7.1.4 Emergent BioSolutions Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Emergent BioSolutions Key News & Latest Developments
7.2 Merial
7.2.1 Merial Company Summary
7.2.2 Merial Business Overview
7.2.3 Merial Anthrax Vaccines Major Product Offerings
7.2.4 Merial Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merial Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Anthrax Vaccines Major Product Offerings
7.3.4 Merck Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Zoetis
7.4.1 Zoetis Company Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Anthrax Vaccines Major Product Offerings
7.4.4 Zoetis Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Zoetis Key News & Latest Developments
7.5 Bayer Sanidad Animal
7.5.1 Bayer Sanidad Animal Company Summary
7.5.2 Bayer Sanidad Animal Business Overview
7.5.3 Bayer Sanidad Animal Anthrax Vaccines Major Product Offerings
7.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Sanidad Animal Key News & Latest Developments
7.6 Colorado Serum
7.6.1 Colorado Serum Company Summary
7.6.2 Colorado Serum Business Overview
7.6.3 Colorado Serum Anthrax Vaccines Major Product Offerings
7.6.4 Colorado Serum Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Colorado Serum Key News & Latest Developments
7.7 PharmAthene
7.7.1 PharmAthene Company Summary
7.7.2 PharmAthene Business Overview
7.7.3 PharmAthene Anthrax Vaccines Major Product Offerings
7.7.4 PharmAthene Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 PharmAthene Key News & Latest Developments
7.8 Tiankang
7.8.1 Tiankang Company Summary
7.8.2 Tiankang Business Overview
7.8.3 Tiankang Anthrax Vaccines Major Product Offerings
7.8.4 Tiankang Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Tiankang Key News & Latest Developments
7.9 Biog?nesis-Bago
7.9.1 Biog?nesis-Bago Company Summary
7.9.2 Biog?nesis-Bago Business Overview
7.9.3 Biog?nesis-Bago Anthrax Vaccines Major Product Offerings
7.9.4 Biog?nesis-Bago Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Biog?nesis-Bago Key News & Latest Developments
7.10 CAVAC
7.10.1 CAVAC Company Summary
7.10.2 CAVAC Business Overview
7.10.3 CAVAC Anthrax Vaccines Major Product Offerings
7.10.4 CAVAC Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 CAVAC Key News & Latest Developments
7.11 Rosenbusch
7.11.1 Rosenbusch Company Summary
7.11.2 Rosenbusch Anthrax Vaccines Business Overview
7.11.3 Rosenbusch Anthrax Vaccines Major Product Offerings
7.11.4 Rosenbusch Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Rosenbusch Key News & Latest Developments
7.12 Agrovet
7.12.1 Agrovet Company Summary
7.12.2 Agrovet Anthrax Vaccines Business Overview
7.12.3 Agrovet Anthrax Vaccines Major Product Offerings
7.12.4 Agrovet Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Agrovet Key News & Latest Developments
7.13 Vecol
7.13.1 Vecol Company Summary
7.13.2 Vecol Anthrax Vaccines Business Overview
7.13.3 Vecol Anthrax Vaccines Major Product Offerings
7.13.4 Vecol Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 Vecol Key News & Latest Developments
7.14 CVCRI
7.14.1 CVCRI Company Summary
7.14.2 CVCRI Business Overview
7.14.3 CVCRI Anthrax Vaccines Major Product Offerings
7.14.4 CVCRI Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 CVCRI Key News & Latest Developments
7.15 IVPM
7.15.1 IVPM Company Summary
7.15.2 IVPM Business Overview
7.15.3 IVPM Anthrax Vaccines Major Product Offerings
7.15.4 IVPM Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 IVPM Key News & Latest Developments
7.16 Prondil
7.16.1 Prondil Company Summary
7.16.2 Prondil Business Overview
7.16.3 Prondil Anthrax Vaccines Major Product Offerings
7.16.4 Prondil Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Prondil Key News & Latest Developments
7.17 CDV
7.17.1 CDV Company Summary
7.17.2 CDV Business Overview
7.17.3 CDV Anthrax Vaccines Major Product Offerings
7.17.4 CDV Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 CDV Key News & Latest Developments
7.18 Indian Immunologicals
7.18.1 Indian Immunologicals Company Summary
7.18.2 Indian Immunologicals Business Overview
7.18.3 Indian Immunologicals Anthrax Vaccines Major Product Offerings
7.18.4 Indian Immunologicals Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.18.5 Indian Immunologicals Key News & Latest Developments
7.19 Botswana Vaccine Institute
7.19.1 Botswana Vaccine Institute Company Summary
7.19.2 Botswana Vaccine Institute Business Overview
7.19.3 Botswana Vaccine Institute Anthrax Vaccines Major Product Offerings
7.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.19.5 Botswana Vaccine Institute Key News & Latest Developments
7.20 Ceva Sant? Animale
7.20.1 Ceva Sant? Animale Company Summary
7.20.2 Ceva Sant? Animale Business Overview
7.20.3 Ceva Sant? Animale Anthrax Vaccines Major Product Offerings
7.20.4 Ceva Sant? Animale Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.20.5 Ceva Sant? Animale Key News & Latest Developments
7.21 Intervac
7.21.1 Intervac Company Summary
7.21.2 Intervac Business Overview
7.21.3 Intervac Anthrax Vaccines Major Product Offerings
7.21.4 Intervac Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.21.5 Intervac Key News & Latest Developments
7.22 JOVAC
7.22.1 JOVAC Company Summary
7.22.2 JOVAC Business Overview
7.22.3 JOVAC Anthrax Vaccines Major Product Offerings
7.22.4 JOVAC Anthrax Vaccines Sales and Revenue in Global (2018-2023)
7.22.5 JOVAC Key News & Latest Developments
8 Global Anthrax Vaccines Production Capacity, Analysis
8.1 Global Anthrax Vaccines Production Capacity, 2018-2029
8.2 Anthrax Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Anthrax Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anthrax Vaccines Supply Chain Analysis
10.1 Anthrax Vaccines Industry Value Chain
10.2 Anthrax Vaccines Upstream Market
10.3 Anthrax Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anthrax Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anthrax Vaccines in Global Market
Table 2. Top Anthrax Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anthrax Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anthrax Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Anthrax Vaccines Sales by Companies, (M Doses), 2018-2023
Table 6. Global Anthrax Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anthrax Vaccines Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Anthrax Vaccines Product Type
Table 9. List of Global Tier 1 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anthrax Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anthrax Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anthrax Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anthrax Vaccines Sales (M Doses), 2018-2023
Table 15. By Type - Global Anthrax Vaccines Sales (M Doses), 2024-2029
Table 16. By Application ? Global Anthrax Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anthrax Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anthrax Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anthrax Vaccines Sales (M Doses), 2018-2023
Table 20. By Application - Global Anthrax Vaccines Sales (M Doses), 2024-2029
Table 21. By Region ? Global Anthrax Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anthrax Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anthrax Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anthrax Vaccines Sales (M Doses), 2018-2023
Table 25. By Region - Global Anthrax Vaccines Sales (M Doses), 2024-2029
Table 26. By Country - North America Anthrax Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anthrax Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anthrax Vaccines Sales, (M Doses), 2018-2023
Table 29. By Country - North America Anthrax Vaccines Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Anthrax Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anthrax Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anthrax Vaccines Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Anthrax Vaccines Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Anthrax Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anthrax Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anthrax Vaccines Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Anthrax Vaccines Sales, (M Doses), 2024-2029
Table 38. By Country - South America Anthrax Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anthrax Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anthrax Vaccines Sales, (M Doses), 2018-2023
Table 41. By Country - South America Anthrax Vaccines Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Anthrax Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anthrax Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anthrax Vaccines Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Anthrax Vaccines Sales, (M Doses), 2024-2029
Table 46. Emergent BioSolutions Company Summary
Table 47. Emergent BioSolutions Anthrax Vaccines Product Offerings
Table 48. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Emergent BioSolutions Key News & Latest Developments
Table 50. Merial Company Summary
Table 51. Merial Anthrax Vaccines Product Offerings
Table 52. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Merial Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Anthrax Vaccines Product Offerings
Table 56. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Zoetis Company Summary
Table 59. Zoetis Anthrax Vaccines Product Offerings
Table 60. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Zoetis Key News & Latest Developments
Table 62. Bayer Sanidad Animal Company Summary
Table 63. Bayer Sanidad Animal Anthrax Vaccines Product Offerings
Table 64. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Bayer Sanidad Animal Key News & Latest Developments
Table 66. Colorado Serum Company Summary
Table 67. Colorado Serum Anthrax Vaccines Product Offerings
Table 68. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Colorado Serum Key News & Latest Developments
Table 70. PharmAthene Company Summary
Table 71. PharmAthene Anthrax Vaccines Product Offerings
Table 72. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. PharmAthene Key News & Latest Developments
Table 74. Tiankang Company Summary
Table 75. Tiankang Anthrax Vaccines Product Offerings
Table 76. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Tiankang Key News & Latest Developments
Table 78. Biog?nesis-Bago Company Summary
Table 79. Biog?nesis-Bago Anthrax Vaccines Product Offerings
Table 80. Biog?nesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Biog?nesis-Bago Key News & Latest Developments
Table 82. CAVAC Company Summary
Table 83. CAVAC Anthrax Vaccines Product Offerings
Table 84. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. CAVAC Key News & Latest Developments
Table 86. Rosenbusch Company Summary
Table 87. Rosenbusch Anthrax Vaccines Product Offerings
Table 88. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. Rosenbusch Key News & Latest Developments
Table 90. Agrovet Company Summary
Table 91. Agrovet Anthrax Vaccines Product Offerings
Table 92. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. Agrovet Key News & Latest Developments
Table 94. Vecol Company Summary
Table 95. Vecol Anthrax Vaccines Product Offerings
Table 96. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Vecol Key News & Latest Developments
Table 98. CVCRI Company Summary
Table 99. CVCRI Anthrax Vaccines Product Offerings
Table 100. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 101. CVCRI Key News & Latest Developments
Table 102. IVPM Company Summary
Table 103. IVPM Anthrax Vaccines Product Offerings
Table 104. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 105. IVPM Key News & Latest Developments
Table 106. Prondil Company Summary
Table 107. Prondil Anthrax Vaccines Product Offerings
Table 108. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 109. Prondil Key News & Latest Developments
Table 110. CDV Company Summary
Table 111. CDV Anthrax Vaccines Product Offerings
Table 112. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 113. CDV Key News & Latest Developments
Table 114. Indian Immunologicals Company Summary
Table 115. Indian Immunologicals Anthrax Vaccines Product Offerings
Table 116. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 117. Indian Immunologicals Key News & Latest Developments
Table 118. Botswana Vaccine Institute Company Summary
Table 119. Botswana Vaccine Institute Anthrax Vaccines Product Offerings
Table 120. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 121. Botswana Vaccine Institute Key News & Latest Developments
Table 122. Ceva Sant? Animale Company Summary
Table 123. Ceva Sant? Animale Anthrax Vaccines Product Offerings
Table 124. Ceva Sant? Animale Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 125. Ceva Sant? Animale Key News & Latest Developments
Table 126. Intervac Company Summary
Table 127. Intervac Anthrax Vaccines Product Offerings
Table 128. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 129. Intervac Key News & Latest Developments
Table 130. JOVAC Company Summary
Table 131. JOVAC Anthrax Vaccines Product Offerings
Table 132. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 133. JOVAC Key News & Latest Developments
Table 134. Anthrax Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 135. Global Anthrax Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 136. Global Anthrax Vaccines Production by Region, 2018-2023 (M Doses)
Table 137. Global Anthrax Vaccines Production by Region, 2024-2029 (M Doses)
Table 138. Anthrax Vaccines Market Opportunities & Trends in Global Market
Table 139. Anthrax Vaccines Market Drivers in Global Market
Table 140. Anthrax Vaccines Market Restraints in Global Market
Table 141. Anthrax Vaccines Raw Materials
Table 142. Anthrax Vaccines Raw Materials Suppliers in Global Market
Table 143. Typical Anthrax Vaccines Downstream
Table 144. Anthrax Vaccines Downstream Clients in Global Market
Table 145. Anthrax Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anthrax Vaccines Segment by Type in 2022
Figure 2. Anthrax Vaccines Segment by Application in 2022
Figure 3. Global Anthrax Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anthrax Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anthrax Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Anthrax Vaccines Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Anthrax Vaccines Revenue in 2022
Figure 9. By Type - Global Anthrax Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anthrax Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Anthrax Vaccines Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Anthrax Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anthrax Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Anthrax Vaccines Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Anthrax Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anthrax Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anthrax Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anthrax Vaccines Sales Market Share, 2018-2029
Figure 23. US Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anthrax Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anthrax Vaccines Sales Market Share, 2018-2029
Figure 37. China Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anthrax Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anthrax Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anthrax Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anthrax Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anthrax Vaccines Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Anthrax Vaccines by Region, 2022 VS 2029
Figure 54. Anthrax Vaccines Industry Value Chain
Figure 55. Marketing Channels
